Global Point-of-care UTI Devices Market Size By Type (Culture-Based Devices, Automated Urine Analyzers), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Point-of-care (POC) UTI Devices Market was valued at USD 1.3 billion in 2023 and is projected to surpass USD 2.6 billion by 2031, expanding at a CAGR of 9.2% during the forecast period from 2023 to 2031. The growth of the market is primarily driven by the increasing prevalence of urinary tract infections (UTIs), rising demand for rapid diagnostics, and technological advancements in point-of-care testing. These compact and user-friendly devices enable healthcare professionals to diagnose UTIs swiftly and accurately, facilitating early intervention and improved patient outcomes.

Drivers:

1. Increasing Prevalence of UTIs:

With UTIs being among the most common bacterial infections globally—especially in women, older adults, and patients with comorbidities—the need for fast, reliable diagnostics is critical. Point-of-care UTI devices provide a timely solution, reducing complications and hospital admissions.

2. Growing Demand for Rapid and Decentralized Testing:

As healthcare shifts toward decentralized care, especially in remote or resource-limited settings, POC UTI diagnostic devices offer a significant advantage by delivering near-instant results without requiring centralized laboratories.

3. Technological Advancements in POC Devices:

Continuous R&D efforts have led to the development of high-sensitivity biosensors, integrated microfluidics, and smartphone-enabled POC devices. These innovations increase diagnostic accuracy and usability in real-world settings.

Restraints:

1. Limited Accuracy in Early Devices:

Some early-stage or low-cost POC UTI devices face challenges related to sensitivity and specificity, potentially resulting in false negatives or positives, which could delay appropriate treatment.

2. Reimbursement and Regulatory Barriers:

Inconsistencies in reimbursement policies and strict regulatory approval processes in certain regions can hinder market penetration, especially for startups and smaller companies.

Opportunity:

1. Rising Demand in Emerging Markets:

Emerging economies with underdeveloped healthcare infrastructure present strong growth potential. Affordable and portable POC UTI devices can bridge diagnostic gaps in rural and low-resource settings.

2. Integration with Telemedicine and Digital Platforms:

The integration of POC UTI devices with telehealth platforms allows seamless sharing of diagnostic data between patients and physicians, enhancing treatment timelines and fostering the growth of home-based diagnostics.

Market by System Type Insights:

The market is segmented by system type into Dipstick Test Devices and Analyzer-based UTI Devices. In 2023, the Analyzer-based UTI Devices segment dominated the market due to higher diagnostic accuracy, digital integration capabilities, and rising use in clinical and urgent care settings. However, dipstick tests remain prevalent in home-use and rural healthcare settings due to their affordability and simplicity.

Market by End-use Insights:

By end-use, the Hospitals and Clinics segment accounted for the largest market share in 2023, driven by higher patient volumes and the need for rapid diagnostics to guide empirical antibiotic treatment. The Homecare Settings segment is expected to witness the fastest growth during the forecast period, as self-testing becomes increasingly popular among patients seeking convenience and privacy.

Market by Regional Insights:

Geographically, North America led the global POC UTI devices market in 2023, accounting for the highest revenue share. This is attributed to the region's advanced healthcare infrastructure, high awareness, and early adoption of innovative diagnostic tools. Asia-Pacific is expected to experience the highest CAGR during the forecast period due to growing healthcare investments, rising incidence of UTIs, and improved access to point-of-care technologies in countries like India and China.

Competitive Scenario:

Key players in the global point-of-care UTI devices market include Siemens Healthineers, Abbott Laboratories, Acon Laboratories Inc., Sysmex Corporation, QuidelOrtho Corporation, Nova Biomedical, Becton Dickinson and Company, and bioMérieux SA. These companies are actively engaged in product development, strategic partnerships, and geographic expansion to enhance their competitive edge.

Scope of Work – Global Point-of-care UTI Devices Market

Report Metric Details

Market Size (2023) USD 1.3 billion

Projected Market Size (2031) USD 2.6 billion

CAGR (2023–2031) 9.2%

Market Segments By System Type (Dipstick, Analyzer-based), By End-use (Hospitals, Homecare, Diagnostic Labs), By Region

Growth Drivers Rising UTI prevalence, demand for rapid diagnostics, integration with digital health platforms

Opportunities Expansion in emerging economies, home-based and telehealth-compatible diagnostics

Key Market Developments:

March 2024 – Abbott Laboratories launched a next-gen POC UTI device integrated with mobile app support, enhancing remote monitoring capabilities.

July 2023 – Siemens Healthineers partnered with a digital health provider to incorporate AI-driven analytics into their POC UTI analyzer.

January 202